The drug would need to be taken long before symptoms first appear—but it could be used to help protect at-risk individuals.

Indiana University School of Medicine scientists have identified a promising drug target for Alzheimer's disease. The team found that removing an enzyme from neurons in the brain substantially reduces ...

Scientists have identified prematurely aged astrocytes in the brains of Alzheimer’s patients, particularly those with the APOE4 risk gene. Their findings suggest that cellular senescence in these ...

Scientists have made a breakthrough in understanding how Alzheimer’s disease develops, and a decades-old drug could be the key to stopping the condition in its tracks. It is well established that ...

The experimental drug lecanemab shows "potential" as an Alzheimer's disease treatment, according to new Phase 3 trial results, but the findings raise some safety concerns because of its association ...

While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in the brain, they have struggled to understand how these harmful fragments are ...

Fri, Feb 13, 2026 A groundbreaking study has discovered that a widely-used medication could help prevent Alzheimer's symptoms ...

With few treatments available to stop or reverse Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of walking back cognitive decline. Alzheimer’s cases are rising in the ...

The country is facing a coming wave of dementia for its ageing population, and is investing in research into drugs, ...

Public Citizen asked the FDA to ban high-dose Aricept because of side effects. May 19, 2011— -- Public Citizen has petitioned the Food and Drug Administration to ban high doses of the Alzheimer's ...